D-1821-2019 Class II Terminated
FDA drug recall D-1821-2019 was initiated by American Health Packaging on Aug 9, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 457 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2019
- Initiation Date
- Aug 9, 2019
- Termination Date
- Nov 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 457 cartons
Product description
Carbamazepine, Extended-Release Tablets, USP, 400 mg, 30 Tablets (3 blister cards x 10 unit doses), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-562-21; NDC Unit Dose: 68084-562-11
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide USA
Code information
Lot 181677, exp 11/30/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1821-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026